Claire Drullion
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Claire Drullion has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Julien Seneschal
Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint‐André, ImmunoConcept, CNRS UMR 5164 Bordeaux University Bordeaux France
2 shared publications - Katia Boniface
University of Bordeaux, CNRS, Immuno ConcEpT, UMR 5164, Bordeaux, France
2 shared publications - Alain Taïeb
INSERM U1312 University of Bordeaux Bordeaux France
1 shared publication - Amélie Valérie Guitart
Medical Research Council Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, United Kingdom
1 shared publication - Angela Ianniciello
Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK
1 shared publication - Arnaud Villacreces
Cellules Souches Hématopoïétiques Normales et Leucémiques, INSERM U1312 BRIC, Université de Bordeaux, Bat TP 4e étage, 146 rue Léo Saignat, 33076 Bordeaux, France
1 shared publication
Latest Publications
- 4 May 2023
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 189 (3) , 312-327
Impact of house dust mite in vitiligo skin: environmental contribution to increased cutaneous immunity and melanocyte detachment
Vitiligo is an autoimmune skin disorder characterized by loss of melanocytes. Protease-mediated disruption of junctions between keratinocytes and/or keratinocyte intrinsic dysfunction may directly contribute to melanocyte loss. House dust mite (HDM), an environmental allergen with potent protease activity, contributes to respiratory and gut disease but also to atopic dermatitis and rosacea. To verify if HDM can contribute to melanocyte detachment in vitiligo and if so, by which mechanism(s). Using primary human keratinocytes, human skin biopsies from healthy and vitiligo patients, and 3D reconstructed human epidermis, we studied the effect of HDM on cutaneous immunity, tight and adherent junction expression and melanocyte detachment. HDM increased keratinocyte production of vitiligo-associated cytokines and chemokines and increased expression of TLR-4. This was associated with increased in situ MMP-9 activity, reduced cutaneous expression of adherent protein E-cadherin, increased soluble E-cadherin in culture supernatant and significantly increased number of supra-basal melanocytes in the skin. This effect was dose-dependent and driven by cysteine protease Der p1 and MMP-9. Selective MMP-9 inhibitor, Ab142180 restored E-cadherin expression and inhibited HDM-induced melanocyte detachment. Keratinocytes from vitiligo patients were more sensitive to HDM-induced changes than healthy keratinocytes. All results were confirmed in 3D model of healthy skin and in human skin biopsies. Our results highlight that environmental mite may act as an external source of PAMPs in vitiligo and topical MMP-9 inhibitors may be useful therapeutic targets. Whether HDM contributes to onset of flares in vitiligo remains to be tested in carefully controlled trials.
- 4 May 2023
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 189 (3) , 312-327
Impact of house dust mite in vitiligo skin: environmental contribution to increased cutaneous immunity and melanocyte detachment
Vitiligo is an autoimmune skin disorder characterized by loss of melanocytes. Protease-mediated disruption of junctions between keratinocytes and/or keratinocyte intrinsic dysfunction may directly contribute to melanocyte loss. House dust mite (HDM), an environmental allergen with potent protease activity, contributes to respiratory and gut disease but also to atopic dermatitis and rosacea. To verify if HDM can contribute to melanocyte detachment in vitiligo and if so, by which mechanism(s). Using primary human keratinocytes, human skin biopsies from healthy and vitiligo patients, and 3D reconstructed human epidermis, we studied the effect of HDM on cutaneous immunity, tight and adherent junction expression and melanocyte detachment. HDM increased keratinocyte production of vitiligo-associated cytokines and chemokines and increased expression of TLR-4. This was associated with increased in situ MMP-9 activity, reduced cutaneous expression of adherent protein E-cadherin, increased soluble E-cadherin in culture supernatant and significantly increased number of supra-basal melanocytes in the skin. This effect was dose-dependent and driven by cysteine protease Der p1 and MMP-9. Selective MMP-9 inhibitor, Ab142180 restored E-cadherin expression and inhibited HDM-induced melanocyte detachment. Keratinocytes from vitiligo patients were more sensitive to HDM-induced changes than healthy keratinocytes. All results were confirmed in 3D model of healthy skin and in human skin biopsies. Our results highlight that environmental mite may act as an external source of PAMPs in vitiligo and topical MMP-9 inhibitors may be useful therapeutic targets. Whether HDM contributes to onset of flares in vitiligo remains to be tested in carefully controlled trials.
- 1 April 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (4) , 1194-1205.e7
Vitiligo Skin T Cells Are Prone to Produce Type 1 and Type 2 Cytokines to Induce Melanocyte Dysfunction and Epidermal Inflammatory Response Through Jak Signaling
- 1 April 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (4) , 1194-1205.e7
Vitiligo Skin T Cells Are Prone to Produce Type 1 and Type 2 Cytokines to Induce Melanocyte Dysfunction and Epidermal Inflammatory Response Through Jak Signaling
- Open Access
- 30 June 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (57) , 96984-96992
Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence
Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence
- 30 June 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (57) , 96984-96992
Open AccessChronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence
Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence